Cleavage of neuronal synaptosomal-associated protein of 25 kDa by exogenous matrix metalloproteinase-7

Journal of Neurochemistry

Volumn 102, Issue 4, 2007, Pages 1256-1263

  Szklarczyk, Arek ^a   Oyler, George ^b   McKay, Ron ^c   Gerfen, Charles ^d   Conant, Katherine ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Veritas Inc   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Endocytosis; Matrilysin; Matrix metalloproteinase 7; Neuron; Synaptosomal associated protein of 25 kDa

Indexed keywords

MATRILYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN SYNAPTOSOME; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENCEPHALITIS; ENDOCYTOSIS; ENZYME SUBSTRATE; NERVE CELL CULTURE; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; RAT; SYNAPTIC MEMBRANE; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; CLATHRIN; EMBRYO; ENDOCYTOSIS; HUMANS; MATRIX METALLOPROTEINASE 7; NEURONS; RATS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TIME FACTORS;

EID: 34547424888     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04625.x     Document Type: Article

References (60)

1. Adair J. C., Charlie J., Dencoff J. E., Kaye J. A., Quinn J. F., Camicioli R. M., Stetler-Stevenson W. G. Rosenberg G. A. (2004) Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke 35, e159 e162.
2. Allen J. A., Yu J. Z., Donati R. J. Rasenick M. M. (2005) Beta-adrenergic receptor stimulation promotes G alpha s internalization through lipid rafts: a study in living cells. Mol. Pharmacol. 67, 1493 1504.
3. Ando K., Kudo Y. Takahashi M. (2005) Negative regulation of neurotransmitter release by calpain: a possible involvement of specific SNAP-25 cleavage. J. Neurochem. 94, 651 658.
4. Apland J. P., Adler M. Oyler G. A. (2003) Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25. J. Protein Chem. 22, 147 153.
5. Asahi M., Wang X., Mori T., Sumii T., Jung J. C., Moskowitz M. A., Fini M. E. Lo E. H. (2001) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724 7732.
6. Ayabe T., Satchell D. P., Wilson C. L., Parks W. C., Selsted M. E. Ouellette A. J. (2000) Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 1, 113 118.
7. Bilousova T. V., Rusakov D. A., Ethell D. W. Ethell I. M. (2006) Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation. J. Neurochem. 97, 44 56.
8. Blobel C. P. (2000) Remarkable roles of proteolysis on and beyond the cell surface. Curr. Opin. Cell Biol. 12, 606 612.
9. Bourke E., Cassetti A., Villa A., Fadlon E., Colotta F. Mantovani A. (2003) IL-1 beta scavenging by the type II IL-1 decoy receptor in human neutrophils. J. Immunol. 170, 5999 6005.
10. Cain C. C. Murphy R. F. (1988) A chloroquine-resistant Swiss 3T3 cell line with a defect in late endocytic acidification. J. Cell Biol. 106, 269 277.
11. Chen Y. A., Scales S. J., Patel S. M., Doung Y. C. Scheller R. H. (1999) SNARE complex formation is triggered by Ca2 + and drives membrane fusion. Cell 97, 165 174.
12. Clements J. M., Cossins J. A., Wells G. M. et al. (1997) Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor. J. Neuroimmunol. 74, 85 94.
13. Conant K., McArthur J. C., Griffin D. E., Sjulson L., Wahl L. M. Irani D. N. (1999) Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann. Neurol. 46, 391 398.
14. Cossins J. A., Clements J. M., Ford J., Miller K. M., Pigott R., Vos W., Van der Valk P. De Groot C. J. (1997) Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol. (Berl.) 94, 590 598.
15. Deb S. Gottschall P. E. (1996) Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J. Neurochem. 66, 1641 1647.
16. Gu Z., Kaul M., Yan B., Kridel S. J., Cui J., Strongin A., Smith J. W., Liddington R. C. Lipton S. A. (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297, 1186 1190.
17. Gutierrez L. M., Viniegra S., Rueda J., Ferrer-Montiel A. V., Canaves J. M. Montal M. (1997) A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells. J. Biol. Chem. 272, 2634 2639.
18. Haughey N. J., Holden C. P., Nath A. Geiger J. D. (1999) Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat. J. Neurochem. 73, 1363 1374.
19. Hautamaki R. D., Kobayashi D. K., Senior R. M. Shapiro S. D. (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277, 2002 2004.
20. Hehr C. L., Hocking J. C. McFarlane S. (2005) Matrix metalloproteinases are required for retinal ganglion cell axon guidance at select decision points. Development 132, 3371 3379.
21. Hess E. J., Jinnah H. A., Kozak C. A. Wilson M. C. (1992) Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the Snap gene on chromosome 2. J. Neurosci. 12, 2865 2874.
22. Kim H. E., Dalal S. S., Young E., Legato M. J., Weisfeldt M. L. D'Armiento J. (2000) Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J. Clin. Invest. 106, 857 866.
23. Knudson W., Chow G. Knudson C. B. (2002) CD44-mediated uptake and degradation of hyaluronan. Matrix Biol. 21, 15 23.
24. Kwan J. A., Schulze C. J., Wang W. et al. (2004) Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J. 18, 690 692.
25. Leake A., Morris C. M. Whateley J. (2000) Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease. Neurosci. Lett. 291, 201 203.
26. Lochter A., Sternlicht M. D., Werb Z. Bissell M. J. (1998) The significance of matrix metalloproteinases during early stages of tumor progression. Ann. N. Y. Acad. Sci. 857, 180 193.
27. Matsuzawa T., Fukui A., Kashimoto T., Nagao K., Oka K., Miyake M. Horiguchi Y. (2004) Bordetella dermonecrotic toxin undergoes proteolytic processing to be translocated from a dynamin-related endosome into the cytoplasm in an acidification-independent manner. J. Biol. Chem. 279, 2866 2872.
28. McCawley L. J. Matrisian L. M. (2001) Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 13, 534 540.
29. Monea S., Jordan B. A., Srivastava S., DeSouza S. Ziff E. B. (2006) Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins. J. Neurosci. 26, 2300 2312.
30. Montecucco C., Schiavo G. Pantano S. (2005) SNARE complexes and neuroexocytosis: how many, how close? Trends Biochem. Sci. 30, 367 372.
31. Murthy V. N. De Camilli P. (2003) Cell biology of the presynaptic terminal. Annu. Rev. Neurosci. 26, 701 728.
32. Nagy V., Bozdagi O., Matynia A. et al. (2006) Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J. Neurosci. 26, 1923 1934.
33. Orii K. O., Grubb J. H., Vogler C. et al. (2005) Defining the pathway for Tat-mediated delivery of beta-glucuronidase in cultured cells and MPS VII mice. Mol. Ther. 12, 345 352.
34. Pereira A. M., Strasberg-Rieber M. Rieber M. (2005) Invasion-associated MMP-2 and MMP-9 are up-regulated intracellularly in concert with apoptosis linked to melanoma cell detachment. Clin. Exp. Metastasis 22, 285 295.
35. Poirier M. A., Xiao W., Macosko J. C., Chan C., Shin Y. K. Bennett M. K. (1998) The synaptic SNARE complex is a parallel four-stranded helical bundle. Nat. Struct. Biol. 5, 765 769.
36. Polyakova V., Hein S., Kostin S., Ziegelhoeffer T. Schaper J. (2004) Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J. Am. Coll. Cardiol. 44, 1609 1618.
37. Raciborska D. A. Charlton M. P. (1999) Retention of cleaved synaptosome-associated protein of 25 kDa (SNAP-25) in neuromuscular junctions: a new hypothesis to explain persistence of botulinum A poisoning. Can. J. Physiol. Pharmacol. 77, 679 688.
38. Reeves T. M., Prins M. L., Zhu J., Povlishock J. T. Phillips L. L. (2003) Matrix metalloproteinase inhibition alters functional and structural correlates of deafferentation-induced sprouting in the dentate gyrus. J. Neurosci. 23, 10182 10189.
39. Rosenberg G. A., Estrada E., Kelley R. O. Kornfeld M. (1993) Bacterial collagenase disrupts extracellular matrix and opens blood-brain barrier in rat. Neurosci. Lett. 160, 117 119.
40. Rothman J. E. Warren G. (1994) Implications of the SNARE hypothesis for intracellular membrane topology and dynamics. Curr. Biol. 4, 220 233.
41. Simpson L. L. (2004) Identification of the major steps in botulinum toxin action. Annu. Rev. Pharmacol. Toxicol. 44, 167 193.
42. Sollner T., Whiteheart S. W., Brunner M., Erdjument-Bromage H., Geromanos S., Tempst P. Rothman J. E. (1993) SNAP receptors implicated in vesicle targeting and fusion. Nature 362, 318 324.
43. Sternlicht M. D. Werb Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463 516.
44. Sudhof T. C. (2004) The synaptic vesicle cycle. Annu. Rev. Neurosci. 27, 509 547.
45. Szklarczyk A., Lapinska J., Rylski M., McKay R. D. Kaczmarek L. (2002) Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 22, 920 930.
46. Takano M., Koyama Y., Nishikawa H., Murakami T. Yumoto R. (2004) Segment-selective absorption of lysozyme in the intestine. Eur. J. Pharmacol. 502, 149 155.
47. Vago R., Marsden C. J., Lord J. M., Ippoliti R., Flavell D. J., Flavell S. U., Ceriotti A. Fabbrini M. S. (2005) Saporin and ricin A chain follow different intracellular routes to enter the cytosol of intoxicated cells. FEBS J. 272, 4983 4995.
48. Vendeville A., Rayne F., Bonhoure A., Bettache N., Montcourrier P. Beaumelle B. (2004) HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol. Biol. Cell 15, 2347 2360.
49. Visse R. Nagase H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827 839.
50. Visser C. C., Stevanovic S., Heleen Voorwinden L., Gaillard P. J., Crommelin D. J., Danhof M. De Boer A. G. (2004) Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro. J. Drug Target. 12, 145 150.
51. Vives E., Richard J. P., Rispal C. Lebleu B. (2003) TAT peptide internalization: seeking the mechanism of entry. Curr. Protein Pept. Sci. 4, 125 132.
52. Vos C. M., Sjulson L., Nath A., McArthur J. C., Pardo C. A., Rothstein J. Conant K. (2000) Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal cultures. Exp. Neurol. 163, 324 330.
53. Wang L. H., Rothberg K. G. Anderson R. G. (1993) Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J. Cell Biol. 123, 1107 1117.
54. van Weert A. W., Dunn K. W., Gueze H. J., Maxfield F. R. Stoorvogel W. (1995) Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump. J. Cell Biol. 130, 821 834.
55. Wilson C. L., Ouellette A. J., Satchell D. P., Ayabe T., Lopez-Boado Y. S., Stratman J. L., Hultgren S. J., Matrisian L. M. Parks W. C. (1999) Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286, 113 117.
56. Yong V. W., Krekoski C. A., Forsyth P. A., Bell R. Edwards D. R. (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21, 75 80.
57. Yu W. H., Woessner J. F. Jr., McNeish J. D. Stamenkovic I. (2002) CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16, 307 323.
58. Yumoto R., Nishikawa H., Okamoto M., Katayama H., Nagai J. Takano M. (2006) Clathrin-mediated endocytosis of FITC-albumin in alveolar type II epithelial cell line RLE-6TN. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L946 L955.
59. Zhang K. M. G., Silva C., Butler G. S., Johnston J. B., Holden J., Clark-Lewis I., Overall C. M. Power C. (2003) HIV-induced metalloproteinase cleavage of the chemokine SDF-1alpha causes neurodegeneration. Nature Neuroscience 6, 1064 1071.
60. Zhao N., Hashida H., Takahashi N. Sakaki Y. (1994) Cloning and sequence analysis of the human SNAP25 cDNA. Gene 145, 313 314.